Диссертация (1173328), страница 22
Текст из файла (страница 22)
50, №4. – P. 492-495.89. Assessing the sensitivity of placental growth factor and soluble fms-liketyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-ageinfants or late-onset preeclampsia: a prospective nested case-control study /T.M.
MacDonald, C. Tran, T.J. Kaitu'u-Lino et al. // BMC PregnancyChildbirth. – 2018. – Vol. 18, № 1. – P. 354.90. Association study between GSTT1 and GSTM1 polymorphisms and risk ofpreeclampsia in Chinese population / L. Guan, P. Fan, X. Liu et al. //136European Journal of Obstetrics & Gynecology and Reproductive Biology. –2016. – Vol. 204. – P. 31-35.91.
Belova, O.G. Sociological aspects of reproductive behavior of young people /O.G. Belova // Reproductive health of children and teenagers. – 2013. – Vol.2, № 49. – P. 59-65.92. Berti, I.R. Chronic hypertension and pregnancy at a tertiary-care anduniversity hospital / I.R.
Berti, D.K. Sochio, R. Bampi // Hypertension inPregnancy. – 2012. – Vol. 31, № 3. – P. 350-356.93. Bilagi, A. Association of maternal serum PAPP-A levels, nuchal translucencyand crown-rump length in first trimester with adverse pregnancy outcomes:retrospective cohort study / A. Bilagi, D.L. Burke // Prenatal. Diagnosis. –2017. – Vol. 37, № 7. – P. 705-711.94.
Bilodeau, J.F. Review: maternal and placental antioxidant response topreeclampsia — impact on vasoactive eicosanoids / J.F. Bilodeau // Placenta.– 2014. – Vol. 35. – P. 32-38.95. Chronic hypertension and adverse pregnancy outcome: a cohort study / A.M.Panaitescu, A. Syngelaki, N. Prodan et al. // Ultrasound in Obstetrics andGynecology. – 2017. – Vol. 50, № 2. – P. 228-235.96. Chronic hypertension: first-trimester blood pressure control and likelihood ofsevere hypertension, preeclampsia, and small for gestational age / D.Nzelu, D. Dumitrascu-Biris, K.H. Nicolaides et al. // American Journal ofObstetrics and Gynecology. – 2018.
– Vol. 218, № 3. – P. 337.97. Clinical and pathogenetic features of early and late onset preeclampsia / Z.S.Khodzhaeva, E.A. Kogan, R.G. Shmakov et al. // Journal of Maternal-FetalNeonatal Medicine. – 2016. – Vol. 29, № 18. – P. 2980-2986.98. Clinical characterization and outcomes of preeclampsia with normalangiogenic profile / S. Rana, W.T. Schnettler, C. Powe et al. // Hypertensionin Pregnancy. – 2013. – Vol. 32.
– P. 189-201.13799. Clinical risk factors for pre-eclampsia determined in early pregnancy:systematic review and meta-analysis of large cohort studies / E. Bartsch, K.E.Medcalf, A.L. Park et al. // BMJ. – 2016. – Vol. 19, № 353. – i1753.100. Comparison of clinical and perinatal outcomes in early- and late-onsetpreeclampsia / R. Madazli, M.A. Yuksel, M. Imamoglu et al.
// Archives ofGynecology and Obstetrics. – 2014. – Vol. 290, № 1. – P. 53-57.101. Complement activation in thrombotic microangiopathies / S. Feng, M.H.Kroll, L. Nolasco et al. // British Journal of haematology. – 2013. – Vol.160, № 3. – P. 404-406.102.
Consensusonthestandardizationofterminologyinthromboticthrombocytopenic purpura and related thrombotic microangiopathies / M.Scully, S. Cataland, P. Coppo et al. // Journal of thrombosis and haemostasis.– 2017. – Vol. 15, № 2. – P. 312-320.103. Cumulative exposure to paternal seminal fluid prior to conception andsubsequent risk of preeclampsia / A.F. Saftlas, L. Rubenstein, K. Prater et al.// Journal of Reproductive Immunology. – 2014. – Vol. 101-102. – P. 104110.104. Davison, J.M.
New aspects in the pathophysiology of preeclampsia / J.M.Davison, V.A. Homuth, J. Jeyabalan // American Society of Nephrology. –2014. – № 15. – P. 2440-2448.105. Dekker, G. The etiology of preeclampsia: the role of the father / G. Dekker,P.Y. Robillard, C. J Roberts // Journal of Reproductive Immunology. – 2011.– № 89. – P. 126-132.106. Di Renzo, G.C. The great obstetrical syndromes / G.C.
Di Renzo // TheJournal of Maternal-Fetal & Neonatal Medicine. – 2009. – Vol. 22, № 8. –P. 633-635.107. Diabetes and preeclampsia Intervention Trial Study Group. Optimal glycemiccontrol, pre-eclampsia, and gestational hypertension in women with type 1diabetes in the diabetes and pre-eclampsia intervention trial / V.A. Holmes,138I.S. Young, C.C.
Patterson et al. // Diabetes Care. – 201. – Vol. 34, № 8. –P. 1683-1688.108. Diagnosis and management of preeclampsia in community settings in low andmiddle-income countries / R.A Salam, J.K. Das, A. Anum // Journal of familymedicine and primary care. – 2015. – Vol. 4, № 4. – P. 501-506.109.
Diagnosis and treatment of hypertensive pregnancy disorders / H. Stepan, S.Kuse-Föhl, W. Klockenbusch et al. // Geburtshilfe Frauenheilkd. – 2015. –Vol. 75, № 9. – P. 900-914.110. Diagnosis, evaluation and management of the hypertensive disorders ofpregnancy: executive summary / L.A. Magee, A. Pels, M. Helewa et al. //Journal of Obstetrics and Gynaecology Canada. – 2014. – Vol. 36, № 5.
–P. 416-441.111. Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placentalgrowth factor ratio for preeclampsia: a meta-analysis based on 20 studies / Y.Liu, Y. Zhao, A. Yu et al. // Archives of Gynecology and Obstetrics. – 2015.– Vol. 292, № 3. – P.
507-518.112. Diagnostic and predictive biomarkers for pre-eclampsia in patients withestablished hypertension and chronic kidney disease / K. Bramham, P.T.Seed, L. Lightstone et al. // Clinical Investigation. – 2016. – Vol. 89. – P. 874885.113. Difference of endothelial function during pregnancies as a method to predictpreeclampsia / A.H. Brandao, L.R. Félix, E. do Carmo Patrício et al. //Archives of Gynecology and Obstetrics.
– 2014. – Vol. 290, № 3. – P. 471477.114. Differentprofileofserumleptinbetweenearlyonsetandlateonset preeclampsia / S. Salimi, F. Farajian-Mashhadi, A. Naghavi et al. //Diseases Markers. – 2014. – Vol. 2014. – Art. No.: 628476. doi:10.1155/2014/628476.115. Differential expression of Vegfr-2 and its soluble form in preeclampsia / C.Munaut et al. PLOS ONE. – 2012. – Vol. 7, № 3.
– e33475.139116. Duckitt, K. Risk factors for preeclampsia at antenatal booking: systematicreview of controlled studies / Duckitt K. // BMJ. – 2005. – № 330. – P. 565.117. Ducray, J.F. Pilot study of comparative placental morphometry in preeclamptic and normotensive pregnancies suggests possible maladaptations ofthe fetal component of the placenta / J.F. Ducray, T. Naicker, J. Moodley //European Journal of Obstetrics Gynecology and Reproductive Biology. –2011. – Vol.
156, №1. – P. 29-34.118. Dude, A.M. Delivery-to-Delivery Weight Gain and Risk of HypertensiveDisorders in a Subsequent Pregnancy / A.M. Dude, S. Shahawy, W.A.Grobman // Obstetrics & Gynecology. – 2018. – Vol.132, № 4. – P. 868-874.119. Early-pregnancy multiple serum markers and second-trimester uterine arteryDoppler in predicting preeclampsia / B. Thilaganathan, B. Wormald, C.Zanardini et al. // Obstetrics & Gynecology.
– 2010. – Vol.115, № 6. –P. 1233-1238.120. Eddy, A.C. Pro-angiogenic therapeutics for preeclampsia / A.C. Eddy, G.L.Bidwell 3rd, E.M. George // Biology of Sex Differences. – 2018. – Vol. 9,№ 1. – P. 36.121. Effect of nicotine on placental ischemia-induced complement activation andhypertension in the rat / C.F. Laule, C.R. Wing, E.J. Odean et al. // Journal ofImmunotoxicology. – 2017. – Vol. 14, № 1. – P. 235-240.122. Endothelial dysfunction and preeclampsia: Role of oxidative stress / L.C.Sanchez-Aranguren, C.E.
Prada, C.E. Riano-Medina et al. // Frontiers inPhysiology.–2014.–Режимдоступа:https://doi.org/10.3389/fphys.2014.00372.123. English, F.A. Risk factors and effective management of preeclampsia / F.A.English, L.C. Kenny, F.P. McCarthy // Integrated Blood Pressure Control. –2015. – Vol. 3, № 8. – P. 7-12.124. ESC Guidelines for the management of cardiovascular diseases duringpregnancy / V. Regitz-Zagrosek, J.W. Roos-Hesselink, J. Bauersachs et al.
//European Heart Journal. –2011. – Vol. 39, № 34. –P. 3165-3241.140125. First trimester hyperglycosylated human chorionic gonadotrophin in serum–amarker of early-onset preeclampsia / E. Keikkala, P. Vuorela, H. Laivuori etal. // Placenta. – 2013. – Vol.34, № 11.– P. 1059-1065.126. Forstermann, U. Nitric oxide synthases: regulation and function / U.Forstermann, W.C. Sessa // European Heart Journal.
– 2012. – № 33. – P.829-837.127. Gestational diabetes modifies the association between PlGF in earlypregnancy and preeclampsia in women with obesity / M.C. Vieira, S. Begum,P.T. Seed et al. // Pregnancy Hypertension. – 2018. – Vol.– 13. – P. 267-272.128. Gestational weight gain and weight loss among women with gestationaldiabetes mellitus / D. Komem, L.
Salman, E. Krispin et al. // DiabetesResearch and Clinical Practice. – 2018. – № 141. – P. 88-97.129. Ghulmiyyah, L. Maternal mortality from preeclampsia/eclampsia / L.Ghulmiyyah, B. Sibai // Seminars in Perinatology. – 2012. – № 36. – P. 5659.130. Giannakou, K. Genetic and non-genetic risk factors for pre-eclampsia:umbrella review of systematic reviews and meta-analyses of observationalstudies / K. Giannakou, E. Evangelou, S.I.
Papatheodorou // Ultrasound inObstetrics & Gynecology. – 2018. – Vol. 51, № 6. – P. 720-730.131. Giannubilo, S.R. Preeclampsia: what could happen in a subsequentpregnancy? / S.R. Giannubilo, B. Landi, A. Ciavattini // Obstetrics &Gynecology Survey. – 2014.
– Vol. 69, № 12. – P. 747-762.132. Humoral immunity in late-onset pre-eclampsia and linkage with angiogenicand inflammatory markers / N. Sarween, M.T. Drayson, J. Hodson et al. //American Journal of Reproductive Immunology. – 2018. – Vol. 80, № 5. –e13041.133. Hviid, T.V. Human leukocyte antigen-G within the male reproductive system:implications for reproduction / T.V. Hviid // Advances in ExperimentalMedicine and Biology. – 2015, № 868. – P. 171-190.141134. Hypertensive disorders of pregnancy / M.A.
Brown, L.A. Magee, L.C. Kennyet al. // Hypertension. – 2018. – Vol. 72, № 1. – P. 24-43.135. Hypertensive disorders of pregnancy: a systematic review of internationalclinical practice guidelines / T.E. Gillon, A. Pels, P. von Dadelszen // PLOSONE. – 2014. – Vol. 9, №12. – e113715.136. Hypertensive disorders of pregnancy: A systematic review of internationalclinical practice guidelines / T.E. Gillon, A. Pels, P. von Dadelszen et al.// PLOS ONE. – 2014. – № 9.
– e113715.137. ICSH recommendations for identification, diagnostic value, and quantitationof schistocytes / G. Zini, G. d'Onofrio, C. Briggs et al. // The InternationalJournal of Laboratory Hematology. – 2012. – Vol. 34, № 2. – P. 107-116.138. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 andprojections for 2045 / N.H. Cho, J.E. Shaw, S.
Karuranga et al. // Diabetesresearch and clinical practice. – 2018. – Vol.138. – 271-281.139. Immunological criteria for differential diagnosis of hypertension in pregnantwomen / I.A. Panova, A.I. Malyshkina, D.A. Khlipunova et al. //Sovremennye tehnologii v medicine. – 2015. – Vol. 7, № 3. – P.103-108.140. Impact of severe ADAMTS13 deficiency on clinical presentation andoutcomes in patients with thrombotic microangiopathies: the experience ofthe Harvard TMA Research Collaborative / P.K. Bendapudi, A. Li, A.Hamdan et al. // British Journal of Haematology.
– 2015. – Vol. 171, № 5. –P. 836-844.141. Impaired placentation in women with chronic hypertension who develop preeclampsia / A.M. Panaitescu, R. Akolekar, N. Kametas et al. // Ultrasound inObstetrics and Gynecology. – 2017. – Vol. 50, № 4. – P. 496-500.142. Implementation of the sFlt-1/PLGD ratio for prediction and diagnosis ofpreeclampsia in in singleton pregnancy: implications for clinical practice / H.Stepan, I. Herraiz, D.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
